SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

Crescendo Biologics Names Incyte VP as Chief Financial Officer

05/10/2021 01:40

05:38 AM EDT, 05/10/2021 (MT Newswires) -- Crescendo Biologics said Monday that Michael Booth, formerly division vise president at Incyte (INCY), has joined the private firm as its chief financial officer.

Booth, who was part of Incyte's investor relations and corporate responsibility division, will be responsible for Crescendo's financial strategy, reporting and investor relations, the company said.

Price: 82.74, Change: +0.43, Percent Change: +0.52